MarketPeel
Insider Trading Intelligence
ZX

Zhenyu Xu

SOPH
CHIEF SCIENTIFIC OFFICER · SOPHIA GENETICS SA · CIK 0002006362
FILING MIX · LIFETIME21%/79%
BUYS
4
SELLS
15
TOTAL VALUE
$197.0K
COMPANIES
1
ACTIVE SINCE
Mar 2026
HOLDINGS NOW
610,887
AVG SELL PX
$4.95
TRADE KIND
SHOWING 19 / 19
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
10 backtested trades · 8 horizons · 31 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Zhenyu Xu, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d10+30.00%+3.23%+2.74%+0.49%+1.31%
14d10+0.00%+2.79%+4.05%-1.26%-1.78%
30d10+40.00%+0.53%+8.85%-7.30%-6.89%
60d10+25.00%+1.95%+9.29%-7.50%-8.42%
90d10(1 pending)+0.00%+11.83%+11.04%+0.79%+5.04%
180d10(10 pending)
1y10(10 pending)
2y10(10 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SOPH · 610,887 shares · as of Jul 13, 2026
0162,513325,026487,539650,052SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
2026
FLOW · 4 buys / 15 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
4,000$5.70$22.8K610,887Jul 13, 2026Jul 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
7,393$5.17$38.2K614,887Jul 6, 2026Jul 7, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
4,000$5.01$20.1K622,280Jun 15, 2026Jun 17, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
608$4.60$2.8K626,280May 19, 2026May 20, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
4,000$4.54$18.2K626,888May 13, 2026May 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
608$5.21$3.2K630,888Apr 20, 2026Apr 21, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
600$4.97$3.0K631,496Apr 14, 2026Apr 16, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
3,400$4.76$16.2K632,096Apr 13, 2026Apr 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
1,014$4.76$4.8K635,496Apr 13, 2026Apr 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
3,706$4.68$17.3K636,510Apr 10, 2026Apr 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
1,936$4.74$9.2K640,216Apr 9, 2026Apr 10, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,800$4.84$13.5K642,152Apr 8, 2026Apr 10, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,400$4.87$11.7K644,952Apr 7, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,700$4.85$13.1K647,352Apr 6, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
164,671164,671Apr 2, 2026Apr 3, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
112,936112,936Apr 2, 2026Apr 3, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
164,671164,671Apr 2, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
112,936650,052Apr 2, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
608$4.78$2.9K537,116Mar 19, 2026Mar 20, 2026View →
Other insiders · SOPH
Loading peer insiders…
About this filer
CIK 0002006362
ROLE
Chief Scientific Officer
PRIMARY
SOPH
COMPANIES
1
ACTIVE SINCE
Mar 2026
MARKETPEEL · /INSIDER/0002006362DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback